IoMT Wearable Devices Patent Landscape Report and Forecast 2024-2032

IoMT Wearable Devices Patent Landscape Report and Forecast 2024-2032

ty. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving industry. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global 3D Printing Medical Devices Patent Landscape Report 2024

Global 3D Printing Medical Devices Industry Size

The global 3D printing medical devices market size was valued at USD 2.6 billion in 2023. The market size is anticipated to grow at a CAGR of 16.8% during the forecast period of 2024-2032 to achieve a value of USD 10.4 billion by 2032. The patent landscape is thriving, led by the United States with over 10,000 patents. Key areas include patient-specific implants and biocompatible materials.

Patent Landscape Report Coverage

This report provides a comprehensive analysis of the global 3D printing medical devices patent landscape. It examines patent trends, key innovations, and emerging technologies in 3D printing medical devices. The report covers patent filings, patent grants, and leading companies, highlighting strategic advancements and innovations shaping the future of 3D printing technology in healthcare. It is an essential resource for stakeholders seeking insights into the intellectual property dynamics and competitive landscape of the 3D printing medical devices industry.

Global 3D Printing Medical Devices Patent Outlook

• The global 3D printing medical devices patent landscape is driven by the demand for personalised healthcare solutions, cost-effective production, and rapid prototyping capabilities. These drivers are reflected in over 10,000 patents focusing on custom implants, biocompatible materials, and advanced manufacturing technologies, facilitating enhanced patient care and improved healthcare outcomes.
• Leading companies, such as OrthoFX LLC and Silverbrook Research Pty Ltd, are at the forefront of innovation, holding substantial patent portfolios. OrthoFX LLC focuses on custom dental aligners, while Silverbrook Research specializes in advanced printing technologies. Their strategic patent filings underscore the industry's emphasis on precision and scalability in medical device manufacturing.
• Significant patent activity is observed across key regions, with the United States holding over 5,000 patents. Europe, particularly Germany and the UK, emphasizes material science and regulatory compliance with 3,800 patents. The Asia Pacific region, including China and Japan, has over 3,200 patents, highlighting their focus on cost-effective and scalable healthcare solutions, positioning these regions as leaders in the 3D printing medical devices industry.

3D Printing Medical Devices Introduction

3D printing medical devices are revolutionising the healthcare industry by offering customised solutions for patient care. These devices enable the production of complex structures like surgical guides, implants, and prosthetics with precision and efficiency. The patent landscape for 3D printing medical devices reflects significant innovation driven by the demand for personalised medical solutions, cost-effectiveness, and rapid prototyping.

• The ability to create patient-specific implants and prosthetics drives patent activity. Devices like 3D-printed dental aligners and customised orthopedic implants are popular due to their precision and adaptability. Over 4,000 patents have been filed focusing on customisation technologies that enhance treatment outcomes and patient satisfaction.
• Innovations in biocompatible and durable materials are key drivers. Materials such as bioresorbable polymers and titanium alloys are common due to their safety and efficacy. Approximately 3,500 patents have been filed, with new materials designed to improve the safety and efficacy of 3D-printed medical devices.
• Meeting stringent healthcare standards is crucial, with devices like CE-certified surgical implants and FDA-approved prosthetics leading patent activity. Over 2,500 patents have been filed to ensure device quality and compliance with international regulations.

These drivers foster a dynamic patent landscape, promoting advancements that improve the precision and accessibility of 3D-printed medical devices.

Global 3D Printing Medical Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation –

Analysis By Component

• 3D Bioprinter
• Material
• Software
• Services

The patent landscape for 3D printing in medical devices is segmented into four key areas: 3D bioprinters, materials, software, and services. Patents in the 3D bioprinter segment focus on innovations in printing technology, enabling precise and complex tissue and organ fabrication. Material-related patents explore the development of biocompatible and customizable substances, essential for producing functional and safe medical implants and tissues. In the software segment, patents address advancements in design, simulation, and control systems that enhance the precision and efficiency of 3D printing processes. The services segment covers patents related to the support and integration of 3D printing into clinical and manufacturing workflows, including maintenance, customization, and training solutions. Together, these segments reflect a comprehensive approach to the development of 3D printing technologies that are increasingly central to medical advancements. 3D Bioprinter leads with over 2,500 patents filed and 500 new applications, focusing on advancements in tissue engineering and organ printing. Material holds around 2,000 patents with 400 new applications, emphasizing biocompatible and innovative printing materials. The software has approximately 1,800 patents and 350 new applications, targeting enhanced design and simulation tools. Services encompass around 1,500 patents with 300 new applications, focusing on comprehensive support and custom solutions for 3D printing in the medical field.

Analysis by Technology

• Electron Beam Melting
• Direct Metal Laser Sintering
• Selective Laser Sintering
• Stereolithography
• Digital Light Processing
• Polyjet

The patent landscape for 3D printing in medical devices reveals significant activity across various technologies. Electron Beam Melting (EBM) is recognized for its precision in manufacturing complex, high-strength components, making it a popular choice in orthopedics and implants. Direct Metal Laser Sintering (DMLS) and Selective Laser Sintering (SLS) are also prominent, with patents highlighting their versatility in producing intricate metal and polymer structures used in customised medical applications. Stereolithography (SLA) and Digital Light Processing (DLP) are frequently patented for their ability to create highly detailed and accurate prototypes, often employed in dental and surgical models. PolyJet technology, noted for its multi-material and color capabilities, has patents focusing on its use in creating anatomical models and surgical guides, emphasizing its role in enhancing preoperative planning and patient-specific treatments. Overall, these technologies drive innovation in personalised healthcare through advancements in medical device manufacturing. Electron beam melting leads with over 3,000 patents filed and 600 new applications, focusing on high-precision metal implants. Direct metal laser sintering holds around 2,800 patents with 550 new applications, emphasizing durable and complex metal structures. Selective laser sintering has approximately 2,500 patents and 500 new applications, targeting versatile and robust material usage. Stereolithography encompasses 2,200 patents with 450 new applications, focusing on high-resolution and detailed printing. Digital light processing holds around 1,800 patents with 350 new applications, emphasizing speed and precision. Polyjet has approximately 1,500 patents with 300 new applications, targeting multi-material and high-quality surface finishes.

Analysis by Application

• Surgical Guides
• Prosthetics Implants

The patent landscape for 3D printing in medical devices is segmented into applications like surgical guides and prosthetic implants. Surgical guides, tailored to patient-specific anatomy, are seeing a surge in patent filings due to advancements in precision and customization. Prosthetic implants also dominate the patent landscape, with innovations focusing on personalized design and material enhancements. Both segments reflect the growing importance of 3D printing technology in improving patient outcomes and driving innovation in medical procedures. Applications like custom prosthetics implants dominate the patent landscape with over 3,500 patents historically and more than 600 new filings recently. This leadership is due to the demand for personalised medical solutions and advancements in biocompatibility and durability, making these devices widely used for improving patient outcomes.

Analysis by End-User

• Hospitals and Surgical Centers
• Dental and Orthopedic Clinics
• Academic Institutions and Research Laboratories
• Pharma-Biotech and Medical Device Companies

The patent landscape for 3D printing in medical devices is segmented across various end-users. Hospitals and surgical centres are key contributors, focusing on innovations that enhance surgical precision and patient outcomes. Dental and orthopedic clinics drive patents related to customised implants and prosthetics. Academic institutions and research laboratories are at the forefront of pioneering research, leading to novel patent filings. Pharma-biotech and medical device companies emphasize patents for drug delivery systems and advanced medical devices, reflecting the diverse applications and ongoing advancements in the field. Among end-users, hospitals and surgical centres lead the patent landscape with over 4,000 patents historically and more than 700 new filings in the last year. This dominance is due to innovations in enhancing surgical precision and patient care, with advancements in patient-specific solutions and on-demand manufacturing of surgical tools.

3D Printing Medical Devices Patent Jurisdiction Analysis

The global patent landscape for 3D printing medical devices is characterised by significant activity across key regions, including the United States, Europe, and Asia Pacific. In the United States, over 5,000 patents have been filed, driven by major companies' focus on integrating advanced technologies and personalisation. In Europe, particularly in Germany and the UK, over 3,800 patents emphasize innovations in material science and regulatory compliance. The Asia Pacific region, notably China and Japan, has filed over 3,200 patents, reflecting a dynamic and expanding healthcare technology landscape, with an emphasis on cost-effective and scalable solutions.

Patent Profile of Key Companies

The patent landscape for 3D printing medical devices is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities:

Sony Semiconductor Solutions Corp: Based in Tokyo, Japan, Sony Semiconductor Solutions Corp. holds over 3,500 patents related to semiconductor technologies, with approximately 500 patents in progress. The company focuses on innovations in imaging sensors and AI integration, aiming to enhance performance and efficiency through advanced semiconductor design and manufacturing processes.

Silverbrook Res Pty Ltd: Based in Sydney, Australia, Silverbrook Research Pty Ltd holds over 4,000 patents related to printing and imaging technologies, with approximately 600 patents in progress. The company focuses on innovations in high-speed and high-resolution printing, aiming to revolutionise the printing industry through cutting-edge printhead design and ink technology.

Hewlett Packard Development Co: Based in Palo Alto, California, Hewlett Packard Development Co. holds over 10,000 patents related to computing and printing technologies, with approximately 1,200 patents in progress. The company focuses on innovations in personal computing and 3D printing, aiming to enhance user experiences through advanced hardware and software integration.

Gen Electric: The company focuses on innovations in healthcare, energy, and aviation, aiming to drive industrial advancements through cutting-edge technology and research.

Pure Storage Inc: Based in Mountain View, California, Pure Storage Inc. holds over 1,000 patents related to data storage technologies, with approximately 200 patents in progress. The company focuses on innovations in flash storage and data management, aiming to enhance data access and reliability through advanced storage solutions and software.

Key Questions Answered in the Global 3D Printing Medical Devices Patent Landscape Report

• What are the key drivers of innovation in the 3D printing medical devices patent landscape?
• How does the patent landscape vary across different regions?
• Which companies are leading in patent filings for 3D printing medical devices?
• What technological advancements are shaping the future of 3D printing in healthcare patent landscape?
• How is the demand for personalised medical solutions influencing patent activity?
• What role do advanced materials play in the patent landscape?
• How are patents addressing the integration of 3D printing with digital health platforms?
• What are the trends in patent filings for surgical guides and instruments?
• How is the Asia Pacific region contributing to the patent landscape for 3D printing?
• What innovations are being developed to improve the safety and efficacy of 3D-printed devices?
• How are hospitals and surgical centers driving patent activity in 3D printing?
• How is patent activity influencing the adoption of 3D printing in dental and orthopedic clinics?

What are the emerging opportunities for stakeholders in the 3D printing medical devices industry?

Reasons to Purchase this Report

This report offers an in-depth analysis of the patent landscape, covering key trends, technological advancements, and regional insights. It provides detailed segmentation and highlights areas of significant innovation and activity. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving industry. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global Neuromodulation Devices Patent Landscape Report 2024

Global Neuromodulation Devices Industry Size

The global neuromodulation devices market reached a value of USD 8.7 billion in 2023. The market is likely to grow at a CAGR of 10.3% during the forecast period of 2024-2032 to reach a market value of USD 20.9 billion by 2032. The neuromodulation devices patent landscape is dynamic, with the United States leading with over 6,000 patents focused on spinal cord and deep brain stimulation technologies.

Patent Landscape Report Coverage

The patent landscape report provides a thorough analysis of the global neuromodulation devices patent landscape, examining patent trends, key innovations, and emerging technologies. It covers patent filings, grants, and leading companies, highlighting strategic advancements shaping the future of neuromodulation technology. The report is an essential resource for stakeholders seeking insights into intellectual property dynamics and the competitive landscape of the neuromodulation devices industry, ensuring they stay informed about ongoing and future innovations.

Global Neuromodulation Devices Patent Outlook

• Innovations in miniaturisation, precision targeting, and AI integration are central to the neuromodulation devices patent landscape, with over 10,000 patents filed globally. These advancements enhance therapeutic efficacy and expand neuromodulation applications, driving future growth.
• Boston Scientific, Medtronic, and Onward Medical are key players, holding significant patent portfolios. These companies focus on developing advanced simulation algorithms and integrating digital health solutions, pushing the boundaries of neuromodulation technologies.
• The United States leads in patent filings, emphasizing technological integration. Europe focuses on device safety and efficacy with substantial patent activity. The Asia Pacific region is rising with a focus on cost-effective solutions, reflecting dynamic growth in neuromodulation innovation.

Neuromodulation Devices Introduction

Neuromodulation devices are pivotal in treating a wide range of neurological disorders by altering nerve activity through targeted delivery of electrical or pharmaceutical agents. These devices are used for pain management, epilepsy, and Parkinson's disease, among others. The patent landscape for neuromodulation devices reflects significant innovation driven by the need for more effective treatments, miniaturisation of devices, and integration with advanced digital technologies.

• Devices like microelectrodes and implantable pulse generators are becoming smaller and more discreet, enhancing patient comfort and compliance. Over 4,000 patents have been filed, focusing on the development of miniaturised components and wearables that improve device usability and patient experience.
• Innovations in precision targeting, such as closed-loop systems and real-time monitoring, are driving patent activity. Approximately 3,500 patents have been filed, with a focus on improving the specificity and efficacy of neuromodulation therapies for various conditions, thereby reducing side effects and enhancing outcomes.
• The incorporation of AI and machine learning in neuromodulation devices for optimising treatment parameters and personalising therapies is a major driver. Around 2,500 patents have been filed, emphasising the development of intelligent systems that adapt to individual patient needs and provide feedback for continuous improvement of therapeutic strategies.

These drivers foster a dynamic patent landscape, promoting cutting-edge innovations that enhance the effectiveness and patient accessibility of neuromodulation therapies.

Global Neuromodulation Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation:

Analysis by Product Type

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Transcranial Magnetic Stimulators
• Others

Based on the patent landscape segment by product type, spinal cord stimulation dominates the neurostimulation devicesindustry with over 5,000 patents filed and 700 new applications recently. Focused on chronic pain management, ongoing research enhances electrode design and stimulation algorithms. Advancements in closed-loop systems that adjust stimulation parameters in real-time improve therapeutic outcomes and reduce side effects, making spinal cord stimulation the preferred choice.

Analysis by Technology

• Internal
• External

Based on the patent landscape segment by technology, internal neuromodulation technologies dominate with over 6,000 patents filed and 800 new applications recently. These devices, such as spinal cord stimulators, focus on chronic pain and neurological disorders. Advancements in implantable materials and battery life are key areas of research. External neuromodulation technologies, with around 2,000 patents filed, include transcranial magnetic stimulators and offer non-invasive treatment options, gaining popularity for their ease of use and expanding therapeutic applications.

Analysis by Application

• Internal Neuromodulation
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Sacral Nerve Stimulation
• Gastric Electric Stimulation
• External Neuromodulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation
• Respiratory Electrical Stimulation
• Others

Based on the patent landscape segment by application, internal neuromodulation applications, particularly spinal cord stimulation, dominate the patent landscape with over 4,500 patents filed and 600 new applications recently. These technologies focus on chronic pain management, with ongoing research enhancing electrode design and stimulation algorithms. Spinal cord stimulation is preferred due to advancements in closed-loop systems that adjust stimulation parameters in real-time, improving therapeutic outcomes and reducing side effects.

Analysis by Indication

• Pain Management
• Neurological Disorders
• Respiratory Disorders
• Others

The patent segmentation by indication includes pain management, neurological disorders, and respiratory disorders. Pain management leads the landscape with over 3,200 patents historically and more than 500 new filings. Innovations focus on optimising device efficacy and reducing adverse effects. Pain management devices are extensively used due to developments in multi-site stimulation technologies that offer personalised treatment regimens, effectively addressing diverse pain conditions.

Analysis by Distribution Channel

• Hospitals
• Specialty Clinics
• Others

The patent segmentation by distribution channel includes hospitals, specialty clinics, and others. Hospitals dominate the patent landscape with over 4,000 patents historically and more than 600 new filings recently. This leadership is driven by innovations in integrated healthcare systems and telemedicine solutions, enhancing treatment delivery and patient outcomes. Hospitals are the primary end-users due to advancements in comprehensive care models that integrate neuromodulation therapies with other treatment modalities for holistic patient management.

Neuromodulation Devices Patent Jurisdiction Analysis

The global patent landscape for neuromodulation devices is characterised by significant activity across key regions, including the United States, Europe, and Asia Pacific. In the United States, over 6,000 patents have been filed, driven by a focus on integrating advanced technologies and digital solutions. In Europe, particularly in Germany and the UK, over 4,000 patents emphasize regulatory compliance and device safety. The Asia Pacific region, notably China and Japan, has filed over 3,500 patents, reflecting a dynamic and expanding healthcare technology landscape with an emphasis on cost-effective solutions.

Patent Profile of Key Companies

The patent landscape for neuromodulation devices is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities:

Boston Scientific Neuromodulation Corp.

Based in Marlborough, Massachusetts, Boston Scientific Neuromodulation Corp. holds over 2,500 patents related to neuromodulation devices, with approximately 300 patents in progress. The company focuses on innovations in spinal cord stimulation and deep brain stimulation technologies, aiming to enhance therapeutic outcomes through advanced simulation algorithms and device integration.

Medtronic Inc.

Based in Dublin, Ireland, Medtronic Inc. holds over 4,000 patents related to neuromodulation devices, with approximately 500 patents in progress. The company focuses on innovations in spinal cord and deep brain stimulation technologies, aiming to enhance therapeutic outcomes through advanced stimulation algorithms and seamless device integration. Medtronic is dedicated to improving patient care with cutting-edge neuromodulation solutions.

Other key players in the industry include Cardiac Pacemakers Inc., Cyberonics Inc., and Advanced Neuromodulation Systems Inc.

Key Questions Answered in the Global Neuromodulation Devices Patent Landscape Report

• How is the patent landscape for neuromodulation devices segmented by technology?
• What are the major patent landscape drivers in the neuromodulation devices industry?
• Which companies are leading in patent filings for neuromodulation devices?
• How does the patent landscape differ between invasive and non-invasive neuromodulation technologies?
• What role does AI play in the innovation of neuromodulation devices and increased patent activities?
• How are patents addressing the miniaturisation of neuromodulation devices?
• What trends are shaping the patent landscape of neuromodulation device patents?
• How does the neuromodulation devices patent landscape vary across different regions?
• What are the challenges in obtaining patents for neuromodulation devices?
• How do patents in the United States differ from those in Europe and the Asia Pacific?
• What is the importance of regulatory compliance in neuromodulation device patents?
• How are hospitals and specialty clinics influencing patent activity in this field?
• What are the emerging opportunities for stakeholders in the neuromodulation devices industry?
• How do neuromodulation device patents contribute to advancements in personalised medicine?

Reasons to Purchase this Report

This report offers an in-depth analysis of the patent landscape, covering key trends, technological advancements, and regional insights. It provides detailed segmentation and highlights areas of significant innovation and activity. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving industry. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global Connected Drug Delivery Devices Patent Landscape Report 2024

Global Connected Drug Delivery Devices Industry Size

The global connected drug delivery devices market attained a value of USD 475.1 billion in 2023.

The market is anticipated to grow at a CAGR of 23.7% during the forecast period of 2024-2032 to attain a value of USD 3221.9 billion by 2032. The landscape is expanding, with the United States leading with over 5,000 patents emphasizing Bluetooth and NFC technologies for enhanced connectivity.

Patent Landscape Report Coverage

This report delivers an exhaustive analysis of the global connected drug delivery devices patent landscape. It delves into patent trends, significant innovations, and emerging technologies within the sector. The report includes a comprehensive overview of patent filings, grants, and the leading companies in the industry. By highlighting strategic advancements and innovations, the report is a vital resource for stakeholders seeking to understand the intellectual property dynamics and competitive landscape of the connected drug delivery devices industry, ensuring they stay abreast of ongoing developments and future directions.

Global Connected Drug Delivery Devices Patent Outlook

• The connected drug delivery devices patent landscape is driven by innovations in connectivity and patient adherence. Key areas include real-time monitoring and integration with digital health platforms, with over 3,500 patents filed for connected inhalers and smart injectors. These innovations enhance treatment outcomes and patient engagement.
• Companies like Becton, Dickinson and Company, Sanofi SA, and Medtronic Inc. are leading the patent landscape. They focus on integrating advanced connectivity technologies in drug delivery systems, with over 4,000 patents filed collectively, highlighting their commitment to enhancing device functionality and patient care.
• The United States leads in patent filings with over 5,000 patents, emphasizing technological integration and compliance. Europe follows with 3,500 patents, focusing on safety and efficacy. The Asia Pacific, particularly China and Japan, contributes with over 3,000 patents, targeting cost-effective and scalable solutions for broader industry access.

Connected Drug Delivery Devices Introduction

Connected drug delivery devices represent a transformative approach in healthcare, integrating digital connectivity with medication administration to enhance treatment adherence and patient monitoring. These devices include connected inhalers, injection systems, and wearable patches that provide real-time data to healthcare providers. The patent landscape for connected drug delivery devices is marked by innovations aimed at improving patient outcomes, medication adherence, and integration with healthcare ecosystems.

• Devices like connected inhalers and smart injectors are equipped with Bluetooth and NFC technologies. Over 3,500 patents have been filed focusing on real-time data transmission and analytics, which aid in monitoring patient adherence and optimising therapy.
• Patents related to mobile apps that synchronize with drug delivery devices are gaining traction, with approximately 2,800 filings emphasizing seamless integration with digital health platforms. These advancements enable personalised healthcare management and timely interventions.
• There is a strong focus on ergonomic designs and user-friendly interfaces in connected devices. Over 2,000 patents highlight innovations in device design that enhance user compliance and improve patient experiences by simplifying the drug administration process.

These drivers foster a dynamic patent landscape, promoting innovations that enhance connectivity, usability, and integration of drug delivery devices in modern healthcare.

Global Connected Drug Delivery Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation:

Analysis by Product Type

• Connected Sensors
• Connected Inhaler Sensors
• Connected Injection Sensors
• Integrated Connected Devices
• Integrated Inhalation Devices
• Integrated Injection Devices
• Others

Based on the patent segmentation by product type, connected sensors and integrated devices lead the patent landscape, with over 4,000 patents filed historically and 600 currently in process. This segment's leadership is driven by innovations in sensor technology that enhance precision and real-time data capture. Advancements include miniaturisation and multi-sensor integration, which allow these devices to provide comprehensive health analytics and personalised drug delivery feedback, making them crucial in the patent landscape.

Analysis by Technology

• Near Field Communication (NFC)
• Bluetooth
• Other

In the patent segment by technology, Bluetooth technology dominate, with over 3,200 patents historically and more than 500 new filings recently. This focus on Bluetooth is due to its widespread use in enabling seamless, low-energy wireless communication between drug delivery devices and mobile applications, enhancing device interoperability and patient adherence monitoring. The patent landscape in this area emphasizes improving connectivity range, security, and data transmission reliability.

Analysis by End User

• Homecare
• Hospitals
• Others

In the patent segmentation by end-user, homecare settings hold the lead in patent filings, with over 2,500 patents historically and more than 400 new patents in the past year. Patents in this area focus on developing user-friendly interfaces and remote monitoring capabilities, reflecting a trend t